329. 無虹彩症 Disease details / Clinical trials / Drug dev / DR info /
臨床試験数 : 3 / 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
Ataluren
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States;
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan;
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States;
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan;